Related Experiment Videos
Angiogenesis in endometrial cancer
A Mazurek1, M Telego, P Pierzyñski
1Institute of Obstetrics and Gynecology, Medical University of Białystok, Poland.
Neoplasma
|April 21, 1999
Summary
This study found higher angiogenesis in endometrial cancer tissues compared to healthy muscle. Increased tumor vascularity correlates with advanced clinical stage, suggesting angiogenesis is a key factor in endometrial cancer progression.
Area of Science:
- Oncology
- Pathology
- Gynecologic Oncology
Background:
- Endometrial adenocarcinoma is a significant gynecologic malignancy.
- Understanding tumor vascularity, or angiogenesis, is crucial for predicting cancer behavior.
Purpose of the Study:
- To evaluate angiogenesis levels in endometrial adenocarcinoma.
- To explore the relationship between tumor vascularity and clinicopathological parameters.
- To compare angiogenesis in tumor tissue versus non-invaded uterine smooth muscle.
Main Methods:
- Analysis of angiogenesis in uterine tissues from 29 post-menopausal women with endometrial cancer.
- Immunohistochemical staining using DAKO EPOS Anti-Human von Willebrand Factor/HRP antibodies to identify endothelial cells.
- Quantification of vessels and endothelial cells using computerized morphometry.
Main Results:
- Highest vessel and endothelial cell density observed in disease-free uterine smooth muscle distant from the tumor.
- Increased vascularity noted in the outer versus central parts of the tumor.
- Statistically significant differences in angiogenic points' density across FIGO stages (Ia, Ib, Ic, II).
- Positive correlation found between clinical stage (FIGO) and angiogenic parameters (total points, endothelial cells, vessels with viable lumen) in tumor center.
Conclusions:
- Angiogenesis analysis may serve as a valuable biologic marker in endometrial cancer.
- Neovascularization plays a significant role in endometrial cancer progression.
- Further research into angiogenesis in endometrial cancer is warranted.